These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 38347719)

  • 41. Drug-Coated Balloon Angioplasty Versus Drug-Eluting Stent Implantation in Patients With Coronary Stent Restenosis.
    Giacoppo D; Alfonso F; Xu B; Claessen BEPM; Adriaenssens T; Jensen C; Pérez-Vizcayno MJ; Kang DY; Degenhardt R; Pleva L; Baan J; Cuesta J; Park DW; Kukla P; Jiménez-Quevedo P; Unverdorben M; Gao R; Naber CK; Park SJ; Henriques JPS; Kastrati A; Byrne RA
    J Am Coll Cardiol; 2020 Jun; 75(21):2664-2678. PubMed ID: 32466881
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A Review on the Comparison of Different Treatments for Carotid In-Stent Restenosis.
    He C; Wang S; Zhou X; Yang Z
    Can J Neurol Sci; 2019 Nov; 46(6):666-681. PubMed ID: 31581961
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy and Prediction Model Construction of Drug-Coated Balloon Combined with Cutting Balloon Angioplasty in the Treatment of Drug-Eluting Stent In-Stent Restenosis.
    Wu H; Yu T; Fan T; Liao W
    Comput Math Methods Med; 2022; 2022():9832622. PubMed ID: 36238492
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Predictors of Long-Term Outcomes After Drug-Eluting Balloon Angioplasty for Bare-Metal Stent Restenosis.
    Hsieh MJ; Huang YC; Yeh JK; Chen CC; Chen DY; Yang CH; Tsai ML; Ho MY; Chang SH; Wang CY; Lee CH; Hsieh IC
    Heart Lung Circ; 2018 May; 27(5):588-594. PubMed ID: 28625598
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mechanisms of acute lumen gain and recurrent restenosis after rotational atherectomy of diffuse in-stent restenosis: a quantitative angiographic and intravascular ultrasound study.
    Radke PW; Klues HG; Haager PK; Hoffmann R; Kastrau F; Reffelmann T; Janssens U; vom Dahl J; Hanrath P
    J Am Coll Cardiol; 1999 Jul; 34(1):33-9. PubMed ID: 10399989
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characteristics of early versus late in-stent restenosis in second-generation drug-eluting stents: an optical coherence tomography study.
    Song L; Mintz GS; Yin D; Yamamoto MH; Chin CY; Matsumura M; Kirtane AJ; Parikh MA; Moses JW; Ali ZA; Shlofmitz RA; Maehara A
    EuroIntervention; 2017 Jun; 13(3):294-302. PubMed ID: 28320686
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Optical coherence tomography study of healing characteristics of paclitaxel-eluting balloons vs. everolimus-eluting stents for in-stent restenosis: the SEDUCE (Safety and Efficacy of a Drug elUting balloon in Coronary artery rEstenosis) randomised clinical trial.
    Adriaenssens T; Dens J; Ughi G; Bennett J; Dubois C; Sinnaeve P; Wiyono S; Coosemans M; Belmans A; D'hooge J; Vrolix M; Desmet W
    EuroIntervention; 2014 Aug; 10(4):439-48. PubMed ID: 25138182
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Outcomes of paclitaxel-coated balloon angioplasty for in-stent calcified nodule: An optical coherence tomography study.
    Masuda H; Kuramitsu S; Ito T; Morofuji T; Domei T; Hyodo M; Shirai S; Ando K
    Catheter Cardiovasc Interv; 2022 Nov; 100(6):990-999. PubMed ID: 36229982
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intravascular Ultrasound-Derived Stent Dimensions as Predictors of Angiographic Restenosis Following Nitinol Stent Implantation in the Superficial Femoral Artery.
    Miki K; Fujii K; Kawasaki D; Shibuya M; Fukunaga M; Imanaka T; Tamaru H; Sumiyoshi A; Nishimura M; Horimatsu T; Saita T; Okada K; Kimura T; Honda Y; Fitzgerald PJ; Masuyama T; Ishihara M
    J Endovasc Ther; 2016 Jun; 23(3):424-32. PubMed ID: 27044270
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Carotid endarterectomy with stent removal for recurring in-stent restenosis: A case report and literature review.
    Takahashi Y; Higashida T; Uchida T; Watanabe S; Kanazawa R
    Surg Neurol Int; 2022; 13():192. PubMed ID: 35673638
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Therapeutic implications of in-stent restenosis located at the stent edge. Insights from the restenosis intra-stent balloon angioplasty versus elective stenting (RIBS) randomized trial.
    Alfonso F; Melgares R; Mainar V; Lezaún R; Vázquez N; Tascón J; Pomar F; Cequier A; Angel J; Pérez-Vizcayno MJ; Sabaté M; Bañuelos C; Fernández C; García JM;
    Eur Heart J; 2004 Oct; 25(20):1829-35. PubMed ID: 15474698
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The impact of tissue characterization for in-stent restenosis with optical coherence tomography during excimer laser coronary angioplasty.
    Hashimoto S; Takahashi A; Mizuguchi Y; Yamada T; Taniguchi N; Hata T; Nakajima S
    Cardiovasc Interv Ther; 2019 Apr; 34(2):171-177. PubMed ID: 30136194
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Open-Label Multicenter Registry on the Outcomes of In-Stent Restenosis Treated by Balloon Angioplasty with Optical Frequency Domain Imaging in the Superficial Femoral Artery (ISLAND-SFA Study).
    Yanaka K; Konishi A; Shinke T; Kozuki A; Kawamori H; Tsukiyama Y; Iida O; Kadotani M; Omori T; Hirata KI
    Ann Vasc Dis; 2020 Sep; 13(3):291-299. PubMed ID: 33384733
    [No Abstract]   [Full Text] [Related]  

  • 54. Treatment of In-Stent Restenosis by Excimer Laser Coronary Atherectomy and Drug-Coated Balloon: Serial Assessment with Optical Coherence Tomography.
    Miyazaki T; Ashikaga T; Fukushima T; Hatano Y; Sasaoka T; Kurihara K; Ono Y; Shimizu S; Otomo K; Hirao K
    J Interv Cardiol; 2019; 2019():6515129. PubMed ID: 31772538
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A randomized comparison of repeat stenting with balloon angioplasty in patients with in-stent restenosis.
    Alfonso F; Zueco J; Cequier A; Mantilla R; Bethencourt A; López-Minguez JR; Angel J; Augé JM; Gómez-Recio M; Morís C; Seabra-Gomes R; Perez-Vizcayno MJ; Macaya C;
    J Am Coll Cardiol; 2003 Sep; 42(5):796-805. PubMed ID: 12957423
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vascular healing responses to paclitaxel coated balloons or everolimus eluting stents for the treatment of in-stent restenosis. Insights from optical coherence tomography.
    McInerney A; Salazar C; Pérez-Vizcayno MJ; Jimenez-Quevedo P; Jiménez-Valero S; Brugaletta S; Romaguera R; Nombela-Franco L; Travieso-Gonzalez A; Jerónimo-Baza A; Tirado-Conte G; Fernández-Ortiz A; Escaned J; Alfonso F; Macaya C; Gonzalo N
    Coron Artery Dis; 2022 Dec; 33(8):609-617. PubMed ID: 36238983
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In-stent restenosis after interventional treatment of carotid artery stenoses: a long-term follow-up of a single center cohort.
    Kammler J; Blessberger H; Lambert T; Kellermair J; Grund M; Nahler A; Lichtenauer M; Schwarz S; Reiter C; Steinwender C; Kypta A
    Clin Res Cardiol; 2017 Jul; 106(7):493-500. PubMed ID: 28180940
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Predictor of subsequent target lesion revascularization in patients with drug-eluting stent restenosis undergoing percutaneous coronary intervention.
    Takasawa Y; Iijima R; Shiba M; Nakamura M; Sugi K
    J Cardiol; 2010 May; 55(3):391-6. PubMed ID: 20350511
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Exacerbated Peri-Stent Contrast Staining on Serial Angiography and Optical Coherence Tomography After Platinum-Chromium Everolimus-Eluting Stent Implantation for Infrapopliteal Artery Lesions.
    Tomoi Y; Kuramitsu S; Soga Y; Hiramori S; Ando K
    Int Heart J; 2018 Jul; 59(4):895-898. PubMed ID: 29794389
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Length and location of post-PIRCS predict percutaneous transluminal angioplasty and stenting-related restenosis in nasopharyngeal cancer.
    Juan YH; Wu CH; Lin TM; Lin CP; Chang FC
    Eur J Radiol; 2023 Aug; 165():110894. PubMed ID: 37290362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.